← All Sponsors
SPONSOR

European Myeloma Network B.V.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Multiple Myeloma
NCT05243797 Phase 3
Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Multiple Myeloma
United States, Argentina, Australia View Trial →